Prostate Cancer and Prostatic Diseases

  • Prostate Cancer and Prostatic Diseases advance online publication 3 May 2016; doi: 10.1038/pcan.2016.13
  • Prostate-specific membrane antigen (PSMA) is a cell surface enzyme that is highly expressed in prostate cancer (PCa) and is currently being extensively explored as a promising target for molecular imaging in a variety of clinical contexts.
  • Other examples of potential promising applications for PSMA PET imaging include non-invasive characterization of primary PCa, staging and treatment planning for PSMA-targeted radiotherapeutics, and guidance of focal therapy for oligometastatic disease.

Read the full article, click here.


@pcan_journal: “State of Art review on
PSMA PET for Prostate Cancer
from experts at Johns Hopkins University. Hot off the press!”


Prostate Cancer and Prostatic Diseases, covering all aspects of prostatic diseases, in particular prostate cancer. The journal is of interest to surgeons, oncologists, clinicians, and researchers involved in disease of the prostate.


Prostate Cancer and Prostatic Diseases